DNA Methylation Changes in Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, and Lung Adenocarcinoma
2011

DNA Methylation Changes in Lung Adenocarcinoma Development

Sample size: 93 publication 10 minutes Evidence: high

Author Information

Author(s): Selamat Suhaida A., Galler Janice S., Joshi Amit D., Fyfe M. Nicky, Campan Mihaela, Siegmund Kimberly D., Kerr Keith M., Laird-Offringa Ite A.

Primary Institution: University of Southern California

Hypothesis

When do abnormal DNA methylation changes occur during the development of lung adenocarcinoma?

Conclusion

The study identifies specific DNA methylation changes that occur at different stages of lung adenocarcinoma development, suggesting a roadmap for early detection.

Supporting Evidence

  • DNA methylation levels were significantly elevated in atypical adenomatous hyperplasia compared to adjacent non-tumor lung.
  • Distinct DNA methylation changes were observed at different stages of lung adenocarcinoma development.
  • Global DNA hypomethylation was significantly associated with invasive adenocarcinoma.

Takeaway

This study looks at how certain changes in DNA can help us understand when lung cancer starts and how it grows.

Methodology

The study used MethyLight, a real-time PCR-based method, to analyze DNA methylation levels in 249 tissue samples from 93 subjects.

Potential Biases

Limited smoking information was available for many subjects, which could affect the results.

Limitations

The study is cross-sectional, which may limit temporal interpretations of the findings.

Participant Demographics

The study included 93 subjects with various stages of lung adenocarcinoma and adjacent non-tumor lung tissue.

Statistical Information

P-Value

<2.1E-14

Statistical Significance

p<0.017

Digital Object Identifier (DOI)

10.1371/journal.pone.0021443

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication